Ischemic preconditioning promotes intrinsic vascularization and enhances survival of implanted cells in an in vivo tissue engineering model

Tissue Engineering - Part A

Volumn 18, Issue 21-22, 2012, Pages 2210-2219

  Lim, Shiang Y ^a   Hsiao, Sarah T ^a   Lokmic, Zerina ^a   Sivakumaran, Priyadharshini ^a   Dusting, Gregory J ^a   Dilley, Rodney J ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CARDIAC MUSCLES; CARDIOMYOCYTES; CASPASE-3; CELL SURVIVAL; CYTOPROTECTIVE EFFECTS; FEMORAL ARTERY OCCLUSION; FIBRIN MATRIX; IMMUNOSTAINING; IN-VIVO; ISCHEMIC INJURIES; ISCHEMIC PRECONDITIONING; MORPHOMETRY; NEONATAL RAT CARDIOMYOCYTES; PARACRINE; POST-IMPLANTATION; REPERFUSION; SPRAGUE-DAWLEY RATS; TISSUE CONSTRUCTS; TISSUE SECTIONS; TUNEL ASSAY; VASCULARIZATION; VASCULARIZED TISSUES;

BIOMATERIALS; BLOOD VESSELS; CELL DEATH; CHEMICAL COMPOUNDS; RATS; TISSUE;

TISSUE ENGINEERING;

RATTUS;

ACRYLIC ACID RESIN; CARBOPOL 940; TISSUE SCAFFOLD;

ANGIOGENESIS; ANIMAL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; HEART MUSCLE CELL; ISCHEMIC PRECONDITIONING; MALE; METHODOLOGY; NEWBORN; ORGAN SIZE; RAT; SPRAGUE DAWLEY RAT; STAINING; TISSUE ENGINEERING; TRANSPLANTATION;

ACRYLIC RESINS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BODY WEIGHT; CELL SURVIVAL; ISCHEMIC PRECONDITIONING; MALE; MODELS, ANIMAL; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84868565475     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0719     Document Type: Article

References (47)

1. Sarig, U., and Machluf, M. Engineering cell platforms for myocardial regeneration. Expert Opin Biol Ther 11, 1055, 2011.
2. Miyagawa, S., Roth, M., Saito, A., Sawa, Y., and Kostin, S. Tissue-engineered cardiac constructs for cardiac repair. Ann Thorac Surg 91, 320, 2011.
3. Miniati, D.N., and Robbins, R.C. Heart transplantation: a thirty-year perspective. Annu Rev Med 53, 189, 2002.
4. Radisic, M., Malda, J., Epping, E., Geng, W., Langer, R., and Vunjak-Novakovic, G. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 93, 332, 2006.
5. Nesselmann, C., Li, W., Ma, N., and Steinhoff, G. Stem cellmediated neovascularization in heart repair. Ther Adv Cardiovasc Dis 4, 27, 2010.
6. Naderi, H., Matin, M.M., and Bahrami, A.R. Review paper: critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems. J Biomater Appl 26, 383, 2011.
7. Shepherd, B.R., Hoying, J.B., and Williams, S.K. Microvascular transplantation after acute myocardial infarction. Tissue Eng 13, 2871, 2007.
8. Lokmic, Z., Stillaert, F., Morrison, W.A., Thompson, E.W., and Mitchell, G.M. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissueengineered construct. FASEB J 21, 511, 2007.
9. Morritt, A.N., Bortolotto, S.K., Dilley, R.J., Han, X., Kompa, A.R., McCombe, D., Wright, C.E., Itescu, S., Angus, J.A., and Morrison, W.A. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115, 353, 2007.
10. Murry, C.E., Jennings, R.B., and Reimer, K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124, 1986.
11. Yellon, D.M., and Downey, J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83, 1113, 2003.
12. Das, M., and Das, D.K. Molecular mechanism of preconditioning. IUBMB Life 60, 199, 2008.
13. Kawata, H., Yoshida, K., Kawamoto, A., Kurioka, H., Takase, E., Sasaki, Y., Hatanaka, K., Kobayashi, M., Ueyama, T., Hashimoto, T., and Dohi, K. Ischemic preconditioning upregulates vascular endothelial growth factor mRNA expression and neovascularization via nuclear translocation of protein kinase C epsilon in the rat ischemic myocardium. Circ Res 88, 696, 2001.
14. Fukuda, S., Kaga, S., Sasaki, H., Zhan, L., Zhu, L., Otani, H., Kalfin, R., Das, D.K., and Maulik, N. Angiogenic signal triggered by ischemic stress induces myocardial repair in rat during chronic infarction. J Mol Cell Cardiol 36, 547, 2004.
15. Maulik, N. Ischemic preconditioning mediated angiogenic response in the heart. Antioxid Redox Signal 6, 413, 2004.
16. Sasaki, H., Fukuda, S., Otani, H., Zhu, L., Yamaura, G., Engelman, R.M., Das, D.K., and Maulik, N. Hypoxic preconditioning triggers myocardial angiogenesis: a novel approach to enhance contractile functional reserve in rat with myocardial infarction. J Mol Cell Cardiol 34, 335, 2002.
17. Ii, M., Nishimura, H., Iwakura, A., Wecker, A., Eaton, E., Asahara, T., and Losordo, D.W. Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 111, 1114, 2005.
18. Gyongyosi, M., Posa, A., Pavo, N., Hemetsberger, R., Kvakan, H., Steiner-Boker, S., Petrasi, Z., Manczur, F., Pavo, I.J., Edes, I.F., Wojta, J., Glogar, D., and Huber, K. Differential effect of ischaemic preconditioning on mobilisation and recruitment of haematopoietic and mesenchymal stem cells in porcine myocardial ischaemia-reperfusion. Thromb Haemost 104, 376, 2010.
19. Kamota, T., Li, T.S., Morikage, N., Murakami, M., Ohshima, M., Kubo, M., Kobayashi, T., Mikamo, A., Ikeda, Y., Matsuzaki, M., and Hamano, K. Ischemic pre-conditioning enhances the mobilization and recruitment of bone marrow stem cells to protect against ischemia/reperfusion injury in the late phase. J Am Coll Cardiol 53, 1814, 2009.
20. Choi, Y.S., Dusting, G.J., Stubbs, S., Arunothayaraj, S., Han, X.L., Collas, P., Morrison, W.A., and Dilley, R.J. Differentiation of human adipose-derived stem cells into beating cardiomyocytes. J Cell Mol Med 14, 878, 2010.
21. Ahmed, T.A., Dare, E.V., and Hincke, M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 14, 199, 2008.
22. Tilkorn, D.J., Bedogni, A., Keramidaris, E., Han, X., Palmer, J.A., Dingle, A.M., Cowling, B.S., Williams, M.D., McKay, S.M., Pepe, L., Deftereos, A., Morrison, W.A., Penington, A.J., and Mitchell, G.M. Implanted myoblast survival is dependent on the degree of vascularization in a novel delayed implantation/prevascularization tissue engineering model. Tissue Eng Part A 16, 165, 2010.
23. Scherle, W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 26, 57, 1970.
24. Hughes, S. Archimedes revisited: a faster, better, cheaper method of accurately measuring the volume of small objects. Phys Educ 40, 468, 2005.
25. Vunjak-Novakovic, G., Tandon, N., Godier, A., Maidhof, R., Marsano, A., Martens, T.P., and Radisic, M. Challenges in cardiac tissue engineering. Tissue Eng Part B Rev 16, 169, 2010.
26. van Hinsbergh, V.W., Collen, A., and Koolwijk, P. Role of fibrin matrix in angiogenesis. AnnNY Acad Sci 936, 426, 2001.
27. Lokmic, Z., Thomas, J.L., Morrison, W.A., Thompson, E.W., and Mitchell, G.M. An endogenously deposited fibrin scaffold determines construct size in the surgically created arteriovenous loop chamber model of tissue engineering. J Vasc Surg 48, 974, 2008.
28. Abcouwer, S.F., Lin, C.M., Wolpert, E.B., Shanmugam, S., Schaefer, E.W., Freeman, W.M., Barber, A.J., and Antonetti, D.A. Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 51, 5920, 2010.
29. Hashimoto, E., Ogita, T., Nakaoka, T., Matsuoka, R., Takao, A., and Kira, Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 267, H1948, 1994.
30. Dvorak, H.F., Nagy, J.A., Feng, D., Brown, L.F., and Dvorak, A.M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237, 97, 1999.
31. van Bruggen,N., Thibodeaux,H., Palmer, J.T., Lee,W.P., Fu, L., Cairns, B., Tumas, D., Gerlai, R., Williams, S.P., van Lookeren Campagne, M., and Ferrara, N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 104, 1613, 1999.
32. Nagy, J.A., Benjamin, L., Zeng, H., Dvorak, A.M., and Dvorak, H.F. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11, 109, 2008.
33. Sasaki, H., Ray, P.S., Zhu, L., Otani, H., Asahara, T., and Maulik, N. Hypoxia/reoxygenation promotes myocardial angiogenesis via an NF kappa B-dependent mechanism in a rat model of chronic myocardial infarction. J Mol Cell Cardiol 33, 283, 2001.
34. Perez-Amodio, S., Tra, W.M., Rakhorst, H.A., Hovius, S.E., and van Neck, J.W. Hypoxia preconditioning of tissueengineered mucosa enhances its angiogenic capacity in vitro. Tissue Eng Part A 17, 1583, 2011.
35. Jiang, F., Zhang, G., Hashimoto, I., Kumar, B.S., Bortolotto, S., Morrison, W.A., and Dusting, G.J. Neovascularization in an arterio-venous loop-containing tissue engineering chamber: role of NADPH oxidase. J Cell Mol Med 12, 2062, 2008.
36. Zvibel, I., Smets, F., and Soriano, H. Anoikis: roadblock to cell transplantation? Cell Transplant 11, 621, 2002.
37. Pong, K. Ischaemic preconditioning: therapeutic implications for stroke? Expert Opin Ther Targets 8, 125, 2004.
38. Peralta, C., Serafin, A., Fernandez-Zabalegui, L., Wu, Z.Y., and Rosello-Catafau, J. Liver ischemic preconditioning: a new strategy for the prevention of ischemia-reperfusion injury. Transplant Proc 35, 1800, 2003.
39. Yamada, F., Saito, T., Abe, T., Tsuchiya, T., Sato, Y., Kenjo, A., Kimura, T., and Gotoh, M. Ischemic preconditioning enhances regenerative capacity of hepatocytes in long-term ischemically damaged rat livers. J Gastroenterol Hepatol 22, 1971, 2007.
40. Bonventre, J.V. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11, 43, 2002.
41. Fang, J., Chen, L., Fan, L., Wu, L., Chen, X., Li, W., Lin, Y., and Wang, W. Enhanced therapeutic effects of mesenchymal stem cells on myocardial infarction by ischemic postconditioning through paracrine mechanisms in rats. J Mol Cell Cardiol 51, 839, 2011.
42. Zhao, Z.Q., and Vinten-Johansen, J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 55, 438, 2002.
43. Kaga, S., Zhan, L., Altaf, E., and Maulik, N. Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol 40, 138, 2006.
44. Merani, S., and Shapiro, A.M. Current status of pancreatic islet transplantation. Clin Sci (Lond) 110, 611, 2006.
45. Fox, I.J., and Roy-Chowdhury, J. Hepatocyte transplantation. J Hepatol 40, 878, 2004.
46. Shokeir, A.A., Harraz, A.M., and El-Din, A.B. Tissue engineering and stem cells: basic principles and applications in urology. Int J Urol 17, 964, 2010.
47. Song, J.J., and Ott, H.C. Bioartificial lung engineering. Am J Transplant 12, 283, 2012.